These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20704492)

  • 1. The present and future control of pertussis.
    Cherry JD
    Clin Infect Dis; 2010 Sep; 51(6):663-7. PubMed ID: 20704492
    [No Abstract]   [Full Text] [Related]  

  • 2. Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults.
    Mertsola J; Van Der Meeren O; He Q; Linko-Parvinen A; Ramakrishnan G; Mannermaa L; Soila M; Pulkkinen M; Jacquet JM
    Clin Infect Dis; 2010 Sep; 51(6):656-62. PubMed ID: 20704493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jan; 60(1):13-5. PubMed ID: 21228763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis.
    Wei SC; Tatti K; Cushing K; Rosen J; Brown K; Cassiday P; Clark T; Olans R; Pawloski L; Martin M; Tondella ML; Martin SW
    Clin Infect Dis; 2010 Aug; 51(3):315-21. PubMed ID: 20578875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of pertussis immune responses to tetanus-diphtheria-acellular pertussis vaccine in health care personnel: implications for outbreak control.
    Kirkland KB; Talbot EA; Decker MD; Edwards KM
    Clin Infect Dis; 2009 Aug; 49(4):584-7. PubMed ID: 19589084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunogenicity and reactogenicity of acellular pertussis vaccines intended for adolescent and adults].
    Zawadka M; Lutyńska A
    Przegl Epidemiol; 2012; 66(1):99-105. PubMed ID: 22708307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
    Zepp F; Habermehl P; Knuf M; Mannhardt-Laakman W; Howe B; Friedland LR
    Vaccine; 2007 Jul; 25(29):5248-52. PubMed ID: 17583395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stop pertussis too.
    McPartlan D
    Nursing; 2007 Apr; 37(4):10. PubMed ID: 17413329
    [No Abstract]   [Full Text] [Related]  

  • 9. Arm your patients against whooping cough.
    Heavey E
    Nursing; 2008 Feb; 38(2):22-3. PubMed ID: 18223407
    [No Abstract]   [Full Text] [Related]  

  • 10. Research aims to boost pertussis control.
    Friedrich MJ
    JAMA; 2011 Jul; 306(1):27-9. PubMed ID: 21730232
    [No Abstract]   [Full Text] [Related]  

  • 11. [Assessment of postvaccinal response in children past pertussis].
    Grzybowska K; Przybyszewski M; Banasik M; Płaneta-Małecka I; Zeman K
    Wiad Lek; 2006; 59(11-12):819-22. PubMed ID: 17427498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bordetella pertussis booster vaccination for health care personnel immediately following a pertussis outbreak in a hospital?
    Birkebaek NH
    Clin Infect Dis; 2009 Aug; 49(4):588-90. PubMed ID: 19589080
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing the risk of pertussis in newborn infants.
    Blangiardi F; Ferrera G
    J Prev Med Hyg; 2009 Dec; 50(4):206-16. PubMed ID: 20812515
    [No Abstract]   [Full Text] [Related]  

  • 15. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
    Black S; Friedland LR; Ensor K; Weston WM; Howe B; Klein NP
    Pediatr Infect Dis J; 2008 Apr; 27(4):341-6. PubMed ID: 18316985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules.
    Pichichero ME; Casey JR; Francis AB; Marsocci SM; Murphy M; Hoeger W; Cleary C
    Clin Pediatr (Phila); 2006 Sep; 45(7):613-20. PubMed ID: 16928838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why do pertussis vaccines fail?
    Cherry JD
    Pediatrics; 2012 May; 129(5):968-70. PubMed ID: 22529282
    [No Abstract]   [Full Text] [Related]  

  • 18. Adacel and Boostrix: Tdap vaccines for adolescents and adults.
    Med Lett Drugs Ther; 2006 Jan; 48(1226):5-6. PubMed ID: 16410756
    [No Abstract]   [Full Text] [Related]  

  • 19. Update on adolescent immunization: review of pertussis and the efficacy, safety, and clinical use of vaccines that contain tetanus-diphtheria-acellular pertussis.
    Wilson TR
    J Pediatr Health Care; 2006; 20(4):229-37. PubMed ID: 16831630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemic pertussis in 2012--the resurgence of a vaccine-preventable disease.
    Cherry JD
    N Engl J Med; 2012 Aug; 367(9):785-7. PubMed ID: 22894554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.